Publications by authors named "Rujia Tang"
Background: Tacrolimus is a substrate of CYP 3A5; to reduce the rate of liver injury and rejection in liver transplant (LT) recipients, it is feasible to optimize the administration of tacrolimus by adding CYP gene polymorphism.
Methods: We divided 151 LT recipients randomly into an optimization group and a control group. All were tested routinely for clinical indicators such as FK506 trough concentration and biochemistry, and their complications and survival were observed.
Electrochemical CO reduction reaction (eCORR) is a viable approach to achieve carbon neutrality. Bismuth-based electrocatalysts demonstrate exceptional selectivity in CO-to-formate conversion, but their reconstruction mechanisms during the eCORR remain elusive. Herein, the reconstruction processes of bismuth molybdate (BiMoO) nanoplates are elucidated during the eCORR.
View Article and Find Full Text PDF[The clinical analysis of orthotopic liver transplantation for primary biliary cirrhosis].
Zhonghua Nei Ke Za Zhi
December 2015
Objective: To analyze the clinical outcome and complications of orthotopic liver transplantation (OLT) for patients with primary biliary cirrhosis(PBC).
Methods: Clinical data of 25 patients with PBC who underwent OLT were analyzed retrospectively. The postoperative cumulative survival rate of the patients was calculated.
Background: Achievement of sustained virological response (SVR) is the main goal of interferon/ribavirin (IFN/RBV) antiviral therapy in patients with hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (OLT). In this study, we have retrospectively evaluated the efficacy and safety of low accelerating dose regimen (LADR) of IFN/RBV in patients with HCV recurrence after OLT.
Material And Methods: Thirty-one patients with HCV recurrent after OLT who were treated with LADR of antiviral therapy were analyzed in our study.
[Study on the patients with liver transplantation associated hyperglycemia].
Zhonghua Gan Zang Bing Za Zhi
May 2011